ONTOLOGY REPORT - ANNOTATIONS
| Term: | Adenocarcinoma |
|
| Accession: | RDO:0002068
|
browse the term
|
| Definition: | A malignant epithelial tumor with a glandular organization. |
| Synonyms: | exact_synonym: | Adenocarcinomas; Basal Cell Adenocarcinoma; Basal Cell Adenocarcinomas; Cribriform Carcinoma; Cribriform Carcinomas; Granular Cell Adenocarcinoma; Granular Cell Adenocarcinomas; Granular Cell Carcinoma; Granular Cell Carcinomas; Malignant Adenoma; Malignant Adenomas; Oxyphilic Adenocarcinoma; Oxyphilic Adenocarcinomas; Tubular Adenocarcinoma; Tubular Adenocarcinomas; Tubular Carcinoma; Tubular Carcinomas |
| | primary_id: | MESH:D000230 |
|
|
Adenocarcinoma
|
| G |
Angpt2 |
angiopoietin 2 |
|
|
ISS |
8 |
18,691,337 |
18,741,551 |
RGD:2314294 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
|
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:2317202 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
Susceptibility |
ISS |
8 |
77,617,517 |
77,624,492 |
RGD:1601607 |
RGD |
| G |
Lta4h |
leukotriene A4 hydrolase |
|
|
ISS |
10 |
92,916,141 |
92,947,641 |
RGD:2316606 |
RGD |
| G |
Nat1 |
N-acetyl transferase 1 |
|
Susceptibility |
ISS |
8 |
70,014,657 |
70,016,003 |
RGD:5131865 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:1642603 |
RGD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
|
ISS |
11 |
116,393,225 |
116,397,989 |
RGD:2311380 |
RGD |
| G |
Strap |
serine/threonine kinase receptor associated protein |
|
|
ISS |
6 |
137,683,603 |
137,700,451 |
RGD:1581429 |
RGD |
Adenocarcinoma Of Esophagus
|
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
|
ISS |
9 |
7,347,374 |
7,360,461 |
RGD:7207058 |
RGD |
| G |
Mmp1a |
matrix metallopeptidase 1a (interstitial collagenase) |
|
Susceptibility |
ISS |
9 |
7,464,141 |
7,476,869 |
RGD:7207058 |
RGD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
|
ISS |
9 |
7,445,822 |
7,455,975 |
RGD:7207058 |
RGD |
Adenocarcinoma of lung
|
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7207787 |
RGD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
|
ISS |
12 |
105,644,918 |
105,652,539 |
RGD:5147446 |
RGD |
Adenocarcinoma, Bronchiolo-Alveolar
|
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
11 |
16,652,206 |
16,813,910 |
RGD:5131465 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
11 |
16,652,206 |
16,813,910 |
RGD:5131630 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
35,020,861 |
35,024,610 |
RGD:5131942 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
|
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:4140940 |
RGD |
Adenocarcinoma, Mucinous
|
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2317980 |
RGD |
| G |
Muc2 |
mucin 2 |
|
|
ISS |
7 |
148,876,261 |
148,890,250 |
RGD:2317985 |
RGD |
| G |
Muc2 |
mucin 2 |
|
|
ISS |
7 |
148,876,261 |
148,890,250 |
RGD:2324887 |
RGD |
| G |
Muc2 |
mucin 2 |
|
|
ISS |
7 |
148,876,261 |
148,890,250 |
RGD:2324868 |
RGD |
| G |
Muc2 |
mucin 2 |
|
|
ISS |
7 |
148,876,261 |
148,890,250 |
RGD:2324889 |
RGD |
| G |
Muc4 |
mucin 4 |
|
Severity |
ISS |
16 |
32,735,972 |
32,782,477 |
RGD:2324927 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
Disease_progression |
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324907 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
|
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324889 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
|
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324887 |
RGD |
| G |
Muc6 |
mucin 6, gastric |
|
|
ISS |
7 |
148,819,948 |
148,841,207 |
RGD:2325166 |
RGD |
Adrenocortical Carcinoma, Hereditary
|
| G |
Trp53 |
transformation related protein 53 |
|
|
ISS |
11 |
69,393,861 |
69,405,375 |
RGD:7240710 |
OMIM |
Carcinoid Tumor
|
| G |
Eno2 |
enolase 2, gamma neuronal |
|
|
ISS |
6 |
124,710,073 |
124,719,527 |
RGD:2293739 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
|
ISS |
19 |
6,334,979 |
6,340,894 |
RGD:2317351 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317635 |
RGD |
Carcinoid Tumors, Intestinal
|
| G |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
|
ISS |
9 |
50,404,445 |
50,411,954 |
RGD:7240710 |
OMIM |
Carcinoma, Acinar Cell
|
| G |
Apc |
adenomatosis polyposis coli |
|
|
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:2317200 |
RGD |
Carcinoma, Ductal, Breast
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
Disease_progression |
ISS |
5 |
8,660,092 |
8,748,570 |
RGD:2315549 |
RGD |
| G |
Ar |
androgen receptor |
|
Severity |
ISS |
X |
95,345,089 |
95,512,486 |
RGD:1643344 |
RGD |
| G |
Aurka |
aurora kinase A |
|
|
ISS |
2 |
172,181,696 |
172,196,006 |
RGD:1643348 |
RGD |
| G |
Brms1 |
breast cancer metastasis-suppressor 1 |
|
Disease_progression |
ISS |
19 |
5,041,404 |
5,049,917 |
RGD:2289400 |
RGD |
| G |
Ccnd3 |
cyclin D3 |
|
Severity |
ISS |
17 |
47,642,000 |
47,736,638 |
RGD:2316016 |
RGD |
| G |
Cd44 |
CD44 antigen |
|
Disease_progression |
ISS |
2 |
102,651,298 |
102,741,822 |
RGD:2289352 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
4 |
88,920,377 |
88,940,523 |
RGD:2289677 |
RGD |
| G |
Csnk1e |
casein kinase 1, epsilon |
|
|
ISS |
15 |
79,248,282 |
79,272,487 |
RGD:2306813 |
RGD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
|
ISS |
16 |
31,664,125 |
31,873,432 |
RGD:2306813 |
RGD |
| G |
Fhit |
fragile histidine triad gene |
|
|
IAGP |
14 |
10,382,608 |
11,994,546 |
RGD:2289894 |
RGD |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
|
ISS |
5 |
148,373,772 |
148,537,564 |
RGD:2289965 |
RGD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
|
ISS |
12 |
75,008,854 |
75,048,517 |
RGD:2306227 |
RGD |
| G |
Inha |
inhibin alpha |
|
|
ISS |
1 |
75,503,652 |
75,506,929 |
RGD:2290390 |
RGD |
| G |
Jup |
junction plakoglobin |
|
Disease_progression |
ISS |
11 |
100,231,933 |
100,259,053 |
RGD:2291882 |
RGD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
Disease_progression |
ISS |
1 |
135,223,789 |
135,226,299 |
RGD:2289400 |
RGD |
| G |
Kit |
kit oncogene |
|
Severity |
ISS |
5 |
75,971,012 |
76,052,747 |
RGD:2292426 |
RGD |
| G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
|
Disease_progression |
ISS |
11 |
65,501,746 |
65,601,799 |
RGD:2289400 |
RGD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
Disease_progression |
ISS |
9 |
7,272,514 |
7,283,333 |
RGD:2293606 |
RGD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
Severity |
ISS |
2 |
132,075,022 |
132,078,916 |
RGD:2315014 |
RGD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
|
ISS |
11 |
53,463,021 |
53,520,821 |
RGD:2300250 |
RGD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
ISS |
16 |
10,783,901 |
10,785,629 |
RGD:2298909 |
RGD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
|
ISS |
10 |
94,874,124 |
94,879,491 |
RGD:2298909 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
11 |
117,827,393 |
117,830,680 |
RGD:2298909 |
RGD |
| G |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
|
|
ISS |
15 |
37,897,083 |
38,008,608 |
RGD:2306813 |
RGD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
Susceptibility |
ISS |
7 |
25,332,169 |
25,358,457 |
RGD:2302569 |
RGD |
Carcinoma, Endometrioid
|
| G |
Areg |
amphiregulin |
|
|
ISS |
5 |
91,568,641 |
91,577,458 |
RGD:2289950 |
RGD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
Disease_progression |
ISS |
8 |
23,104,820 |
23,170,546 |
RGD:2298864 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
ISS |
11 |
117,710,551 |
117,717,057 |
RGD:2298940 |
RGD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
|
ISS |
14 |
47,003,195 |
47,010,274 |
RGD:2296026 |
RGD |
| G |
Car9 |
carbonic anhydrase 9 |
|
|
ISS |
4 |
43,519,898 |
43,526,597 |
RGD:2298945 |
RGD |
| G |
Ccne1 |
cyclin E1 |
|
|
ISS |
7 |
38,883,003 |
38,892,509 |
RGD:2289230 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:2296045 |
RGD |
| G |
Cdk2 |
cyclin-dependent kinase 2 |
|
Severity |
ISS |
10 |
128,134,995 |
128,142,107 |
RGD:2298990 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
ISS |
6 |
134,870,419 |
134,875,543 |
RGD:2299091 |
RGD |
| G |
Chek2 |
checkpoint kinase 2 |
|
Susceptibility |
ISS |
5 |
111,269,036 |
111,303,152 |
RGD:2293868 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:2289817 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
11 |
16,652,206 |
16,813,910 |
RGD:2289950 |
RGD |
| G |
Eno2 |
enolase 2, gamma neuronal |
|
|
ISS |
6 |
124,710,073 |
124,719,527 |
RGD:2293737 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289950 |
RGD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
|
ISS |
10 |
128,006,424 |
128,026,557 |
RGD:2289950 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISS |
1 |
68,086,540 |
69,154,633 |
RGD:2289950 |
RGD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
|
ISS |
7 |
137,305,965 |
137,410,322 |
RGD:2289862 |
RGD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
Disease_progression |
ISS |
11 |
7,106,089 |
7,113,926 |
RGD:2301465 |
RGD |
| G |
Inha |
inhibin alpha |
|
|
ISS |
1 |
75,503,652 |
75,506,929 |
RGD:2290368 |
RGD |
| G |
Inhba |
inhibin beta-A |
|
|
ISS |
13 |
16,106,308 |
16,119,044 |
RGD:2301688 |
RGD |
| G |
Kdr |
kinase insert domain protein receptor |
|
Severity |
ISS |
5 |
76,329,290 |
76,374,453 |
RGD:2291929 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
6 |
145,165,219 |
145,198,751 |
RGD:2314910 |
RGD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
|
ISS |
17 |
17,664,687 |
17,761,453 |
RGD:2314922 |
RGD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
|
ISS |
12 |
57,632,922 |
57,637,895 |
RGD:2290483 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISS |
5 |
75,548,316 |
75,594,229 |
RGD:2298578 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
61,204,804 |
61,244,721 |
RGD:2298578 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
19 |
32,832,067 |
32,900,650 |
RGD:2289817 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
5 |
104,869,403 |
104,879,477 |
RGD:1581360 |
RGD |
| G |
St14 |
suppression of tumorigenicity 14 (colon carcinoma) |
|
|
ISS |
9 |
30,896,175 |
30,939,384 |
RGD:2315091 |
RGD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
|
ISS |
10 |
120,471,060 |
120,537,698 |
RGD:2298535 |
RGD |
Carcinoma, Hepatocellular
|
| G |
A2m |
alpha-2-macroglobulin |
|
|
ISS |
6 |
121,586,191 |
121,629,256 |
RGD:1358261 |
RGD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
|
ISS |
4 |
53,043,661 |
53,172,767 |
RGD:1598532 |
RGD |
| G |
Akt2 |
thymoma viral proto-oncogene 2 |
|
|
ISS |
7 |
28,376,579 |
28,424,472 |
RGD:2313299 |
RGD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
|
ISS |
11 |
78,137,700 |
78,140,262 |
RGD:2301136 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
|
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:7240710 |
OMIM |
| G |
Apoe |
apolipoprotein E |
|
|
IEP |
7 |
20,281,593 |
20,284,515 |
RGD:6903288 |
RGD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
|
ISS |
8 |
125,098,537 |
125,100,807 |
RGD:5135035 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
ISS |
10 |
24,635,013 |
24,647,276 |
RGD:4140476 |
RGD |
| G |
Asns |
asparagine synthetase |
|
|
ISS |
6 |
7,625,171 |
7,643,182 |
RGD:2316006 |
RGD |
| G |
Ass1 |
argininosuccinate synthetase 1 |
|
|
ISS |
2 |
31,325,790 |
31,376,190 |
RGD:4140479 |
RGD |
| G |
Axin1 |
axin 1 |
|
|
ISS |
17 |
26,275,631 |
26,332,756 |
RGD:7240710 |
OMIM |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
|
ISS |
5 |
31,357,184 |
31,380,852 |
RGD:2303530 |
RGD |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
|
ISS |
5 |
31,357,184 |
31,380,852 |
RGD:5132587 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISS |
9 |
47,338,435 |
47,661,468 |
RGD:2289095 |
RGD |
| G |
Capn3 |
calpain 3 |
|
|
NAS |
2 |
120,289,329 |
120,330,655 |
RGD:1600777 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
1 |
58,852,218 |
58,904,347 |
RGD:7240710 |
OMIM |
| G |
Ccne1 |
cyclin E1 |
|
|
ISS |
7 |
38,883,003 |
38,892,509 |
RGD:2289277 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
IPM |
X |
54,465,320 |
54,477,219 |
RGD:2313413 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:2289638 |
RGD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
|
ISS |
10 |
68,799,383 |
68,815,660 |
RGD:2316317 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
4 |
88,920,377 |
88,940,523 |
RGD:1600816 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
4 |
88,920,377 |
88,940,523 |
RGD:1600822 |
RGD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
Severity |
ISS |
10 |
76,514,924 |
76,629,275 |
RGD:1600906 |
RGD |
| G |
COX1 |
cytochrome c oxidase I, mitochondrial |
|
|
ISS |
MT |
5,328 |
6,872 |
RGD:2302301 |
RGD |
| G |
Csk |
c-src tyrosine kinase |
|
|
ISS |
9 |
57,474,453 |
57,492,987 |
RGD:5134372 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:734850 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:7240710 |
OMIM |
| G |
Ctsb |
cathepsin B |
|
|
ISS |
14 |
63,741,302 |
63,764,758 |
RGD:2315605 |
RGD |
| G |
Ctsl |
cathepsin L |
|
|
ISS |
13 |
64,464,522 |
64,471,614 |
RGD:2315605 |
RGD |
| G |
Ep300 |
E1A binding protein p300 |
|
|
ISS |
15 |
81,416,644 |
81,482,507 |
RGD:2312274 |
RGD |
| G |
Fth1 |
ferritin heavy chain 1 |
|
|
ISS |
19 |
10,057,193 |
10,059,582 |
RGD:632698 |
RGD |
| G |
Gc |
group specific component |
|
|
ISS |
5 |
89,846,547 |
89,886,790 |
RGD:5509919 |
RGD |
| G |
Gmps |
guanine monophosphate synthetase |
|
|
ISS |
3 |
63,780,065 |
63,823,000 |
RGD:5135537 |
RGD |
| G |
H19 |
H19 fetal liver mRNA |
|
|
ISS |
7 |
149,761,437 |
149,764,051 |
RGD:2306187 |
RGD |
| G |
Hprt |
hypoxanthine guanine phosphoribosyl transferase |
|
|
ISS |
X |
50,341,255 |
50,374,837 |
RGD:5135035 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISS |
7 |
149,836,673 |
149,846,940 |
RGD:2311523 |
RGD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
|
ISS |
17 |
12,875,272 |
12,962,572 |
RGD:1624323 |
RGD |
| G |
Il6st |
interleukin 6 signal transducer |
|
|
ISS |
13 |
113,254,278 |
113,297,068 |
RGD:1626706 |
RGD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
|
ISS |
4 |
58,448,124 |
58,566,363 |
RGD:2317680 |
RGD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
Susceptibility |
ISS |
10 |
117,125,961 |
117,147,772 |
RGD:2317357 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317495 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:1600123 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317575 |
RGD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
|
|
ISS |
6 |
83,255,698 |
83,267,598 |
RGD:2302305 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
IPM |
15 |
61,816,896 |
61,821,916 |
RGD:6903288 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7240695 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Treatment |
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7240567 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Severity |
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7241004 |
RGD |
| G |
ND5 |
NADH dehydrogenase 5, mitochondrial |
|
|
ISS |
MT |
11,742 |
13,565 |
RGD:2302316 |
RGD |
| G |
Pdgfrl |
platelet-derived growth factor receptor-like |
|
|
ISS |
8 |
42,011,587 |
42,076,136 |
RGD:7240710 |
OMIM |
| G |
Pfas |
phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) |
|
|
ISS |
11 |
68,799,203 |
68,821,962 |
RGD:5135276 |
RGD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
|
ISS |
3 |
32,335,073 |
32,367,408 |
RGD:2290476 |
RGD |
| G |
Pik3ca |
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
|
|
ISS |
3 |
32,335,073 |
32,367,408 |
RGD:7240710 |
OMIM |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
|
ISS |
5 |
77,342,274 |
77,380,603 |
RGD:5135035 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2300283 |
RGD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
|
ISS |
15 |
73,035,535 |
73,253,621 |
RGD:2292584 |
RGD |
| G |
Recql |
RecQ protein-like |
|
Disease_progression |
ISS |
6 |
142,310,420 |
142,335,607 |
RGD:2317370 |
RGD |
| G |
Shc1 |
src homology 2 domain-containing transforming protein C1 |
|
|
ISS |
3 |
89,222,473 |
89,233,951 |
RGD:1643188 |
RGD |
| G |
Skp2 |
S-phase kinase-associated protein 2 (p45) |
|
|
ISS |
15 |
9,041,742 |
9,070,207 |
RGD:2315050 |
RGD |
| G |
Soat2 |
sterol O-acyltransferase 2 |
|
|
ISS |
15 |
101,981,006 |
101,993,867 |
RGD:1581190 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
17 |
13,200,705 |
13,210,985 |
RGD:1581242 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
5 |
104,869,403 |
104,879,477 |
RGD:1581375 |
RGD |
| G |
Srf |
serum response factor |
|
|
ISS |
17 |
46,683,788 |
46,693,111 |
RGD:1581428 |
RGD |
| G |
Tek |
endothelial-specific receptor tyrosine kinase |
|
|
ISS |
4 |
94,405,991 |
94,541,630 |
RGD:1601490 |
RGD |
| G |
Tfrc |
transferrin receptor |
|
|
ISS |
16 |
32,608,982 |
32,632,880 |
RGD:2292036 |
RGD |
| G |
Tgfa |
transforming growth factor alpha |
|
|
ISS |
6 |
86,145,245 |
86,225,443 |
RGD:2317471 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
9 |
115,996,813 |
116,084,481 |
RGD:1601598 |
RGD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
|
IED |
17 |
57,244,808 |
57,247,180 |
RGD:2317348 |
RGD |
| G |
Trp53 |
transformation related protein 53 |
|
|
ISS |
11 |
69,393,861 |
69,405,375 |
RGD:7240710 |
OMIM |
| G |
Tspy-ps |
testis specific protein-Y encoded, pseudogene |
|
|
ISS |
Y |
392,207 |
395,311 |
RGD:2315447 |
RGD |
| G |
Vav1 |
vav 1 oncogene |
|
|
ISS |
17 |
57,418,523 |
57,468,659 |
RGD:2306008 |
RGD |
| G |
Xdh |
xanthine dehydrogenase |
|
|
ISS |
17 |
74,233,248 |
74,299,522 |
RGD:5135059 |
RGD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
|
IEA |
7 |
25,332,169 |
25,358,457 |
RGD:1331525 |
RGD |
Carcinoma, Intraductal, Noninfiltrating
|
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
|
ISS |
14 |
51,710,752 |
51,721,684 |
RGD:2325702 |
RGD |
| G |
Ar |
androgen receptor |
|
|
ISS |
X |
95,345,089 |
95,512,486 |
RGD:1643341 |
RGD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
Disease_progression |
ISS |
1 |
108,434,756 |
108,610,867 |
RGD:2289659 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
Disease_progression |
ISS |
11 |
117,710,551 |
117,717,057 |
RGD:2293106 |
RGD |
| G |
Brca2 |
breast cancer 2 |
|
Onset |
ISS |
5 |
151,325,198 |
151,372,324 |
RGD:2289048 |
RGD |
| G |
Casp6 |
caspase 6 |
|
|
ISS |
3 |
129,604,343 |
129,617,020 |
RGD:2301339 |
RGD |
| G |
Ccnd1 |
cyclin D1 |
|
|
ISS |
7 |
152,115,836 |
152,125,830 |
RGD:2289132 |
RGD |
| G |
Ccnd2 |
cyclin D2 |
|
|
ISS |
6 |
127,075,726 |
127,101,066 |
RGD:2289156 |
RGD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
Disease_progression |
ISS |
17 |
29,227,931 |
29,237,667 |
RGD:2289659 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
Disease_progression |
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289981 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289931 |
RGD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
|
ISS |
10 |
128,006,424 |
128,026,557 |
RGD:2289952 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
Disease_progression |
ISS |
1 |
68,086,540 |
69,154,633 |
RGD:2289981 |
RGD |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
No_Association |
ISS |
5 |
148,373,772 |
148,537,564 |
RGD:2289965 |
RGD |
| G |
Fosl1 |
fos-like antigen 1 |
|
|
ISS |
19 |
5,447,698 |
5,455,938 |
RGD:2293756 |
RGD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
|
ISS |
12 |
75,008,854 |
75,048,517 |
RGD:2306227 |
RGD |
| G |
Hoxb13 |
homeobox B13 |
|
|
ISS |
11 |
96,055,675 |
96,057,913 |
RGD:2314726 |
RGD |
| G |
Klk10 |
kallikrein related-peptidase 10 |
|
Disease_progression |
ISS |
7 |
51,036,424 |
51,040,780 |
RGD:2314849 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2290392 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2290436 |
RGD |
| G |
Notch4 |
notch 4 |
|
|
ISS |
17 |
34,701,240 |
34,725,488 |
RGD:2299156 |
RGD |
| G |
Pgr |
progesterone receptor |
|
Disease_progression |
ISS |
9 |
8,899,833 |
8,968,611 |
RGD:2289659 |
RGD |
| G |
Prkca |
protein kinase C, alpha |
|
|
ISS |
11 |
107,794,701 |
108,205,202 |
RGD:2292458 |
RGD |
| G |
Ptges |
prostaglandin E synthase |
|
|
ISS |
2 |
30,744,991 |
30,758,817 |
RGD:2300083 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2300203 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Disease_progression |
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2300199 |
RGD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
|
ISS |
15 |
73,035,535 |
73,253,621 |
RGD:2292561 |
RGD |
| G |
Rb1 |
retinoblastoma 1 |
|
|
ISS |
14 |
73,595,309 |
73,725,598 |
RGD:2299890 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
ISS |
19 |
5,637,490 |
5,648,130 |
RGD:2298754 |
RGD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
ISS |
16 |
10,783,901 |
10,785,629 |
RGD:2298909 |
RGD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
|
ISS |
10 |
94,874,124 |
94,879,491 |
RGD:2298909 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
11 |
117,827,393 |
117,830,680 |
RGD:2298909 |
RGD |
| G |
Src |
Rous sarcoma oncogene |
|
Severity |
ISS |
2 |
157,250,029 |
157,297,574 |
RGD:2315078 |
RGD |
| G |
St14 |
suppression of tumorigenicity 14 (colon carcinoma) |
|
|
ISS |
9 |
30,896,175 |
30,939,384 |
RGD:2315089 |
RGD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
ISS |
11 |
100,720,665 |
100,746,483 |
RGD:2291930 |
RGD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
ISS |
11 |
100,720,665 |
100,746,483 |
RGD:2291932 |
RGD |
| G |
Tert |
telomerase reverse transcriptase |
|
|
ISS |
13 |
73,764,449 |
73,786,489 |
RGD:2291992 |
RGD |
| G |
Tff1 |
trefoil factor 1 |
|
|
ISS |
17 |
31,298,341 |
31,301,998 |
RGD:2292005 |
RGD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
|
ISS |
11 |
118,162,375 |
118,216,725 |
RGD:2290436 |
RGD |
| G |
Timp4 |
tissue inhibitor of metalloproteinase 4 |
|
|
ISS |
6 |
115,195,634 |
115,201,867 |
RGD:2290436 |
RGD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
Severity |
ISS |
11 |
98,854,261 |
98,885,503 |
RGD:2315133 |
RGD |
| G |
Trp53 |
transformation related protein 53 |
|
|
ISS |
11 |
69,393,861 |
69,405,375 |
RGD:2289931 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
|
ISS |
15 |
89,202,362 |
89,207,467 |
RGD:2293726 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
|
ISS |
17 |
46,153,942 |
46,169,326 |
RGD:2315458 |
RGD |
Carcinoma, Islet Cell
|
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317661 |
RGD |
Carcinoma, Lobular
|
| G |
Ccnd1 |
cyclin D1 |
|
|
ISS |
7 |
152,115,836 |
152,125,830 |
RGD:2289133 |
RGD |
| G |
Ccnd2 |
cyclin D2 |
|
|
ISS |
6 |
127,075,726 |
127,101,066 |
RGD:2289156 |
RGD |
| G |
Cd44 |
CD44 antigen |
|
|
ISS |
2 |
102,651,298 |
102,741,822 |
RGD:2289362 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:2289450 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:2289492 |
RGD |
| G |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
|
|
ISS |
18 |
35,278,566 |
35,414,429 |
RGD:2289795 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
|
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:2289814 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
Severity |
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289935 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
1 |
163,710,820 |
163,718,626 |
RGD:2290134 |
RGD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
ISS |
11 |
100,720,665 |
100,746,483 |
RGD:2291932 |
RGD |
Carcinoma, Neuroendocrine
|
| G |
Eno2 |
enolase 2, gamma neuronal |
|
|
ISS |
6 |
124,710,073 |
124,719,527 |
RGD:2293735 |
RGD |
Carcinoma, Pancreatic Ductal
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
11 |
105,829,261 |
105,851,259 |
RGD:2325211 |
RGD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
|
ISS |
X |
160,577,274 |
160,626,350 |
RGD:2325210 |
RGD |
| G |
Adam8 |
a disintegrin and metallopeptidase domain 8 |
|
Disease_progression |
ISS |
7 |
147,164,840 |
147,178,387 |
RGD:2325243 |
RGD |
| G |
Adam9 |
a disintegrin and metallopeptidase domain 9 (meltrin gamma) |
|
Disease_progression |
ISS |
8 |
26,060,083 |
26,127,394 |
RGD:2325249 |
RGD |
| G |
Agr2 |
anterior gradient 2 (Xenopus laevis) |
|
|
ISS |
12 |
36,719,512 |
36,730,668 |
RGD:2325659 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
5 |
90,889,915 |
90,905,629 |
RGD:2325677 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
|
ISS |
9 |
69,301,490 |
69,339,592 |
RGD:2325731 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
Disease_progression |
ISS |
9 |
69,301,490 |
69,339,592 |
RGD:2317307 |
RGD |
| G |
Anxa5 |
annexin A5 |
|
|
ISS |
3 |
36,347,845 |
36,374,809 |
RGD:2317538 |
RGD |
| G |
Anxa8 |
annexin A8 |
|
|
ISS |
14 |
34,899,176 |
34,913,757 |
RGD:2325735 |
RGD |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISS |
7 |
20,274,830 |
20,278,007 |
RGD:2325793 |
RGD |
| G |
Calr |
calreticulin |
|
|
ISS |
8 |
87,365,987 |
87,370,830 |
RGD:2326165 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
5 |
54,089,724 |
54,098,943 |
RGD:4110818 |
RGD |
| G |
Cckar |
cholecystokinin A receptor |
|
|
ISS |
5 |
54,089,724 |
54,098,943 |
RGD:4110816 |
RGD |
| G |
Cckbr |
cholecystokinin B receptor |
|
|
ISS |
7 |
112,574,334 |
112,584,852 |
RGD:4110816 |
RGD |
| G |
Cd40 |
CD40 antigen |
|
|
IED |
2 |
164,881,136 |
164,897,154 |
RGD:5490301 |
RGD |
| G |
Cd40 |
CD40 antigen |
|
|
ISS |
2 |
164,881,136 |
164,897,154 |
RGD:5490524 |
RGD |
| G |
Cldn4 |
claudin 4 |
|
|
ISS |
5 |
135,420,993 |
135,422,804 |
RGD:2317592 |
RGD |
| G |
Egf |
epidermal growth factor |
|
Disease_progression |
ISS |
3 |
129,380,493 |
129,458,240 |
RGD:2317644 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
1 |
163,710,820 |
163,718,626 |
RGD:2317747 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
1 |
163,710,820 |
163,718,626 |
RGD:2317741 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
3 |
37,247,575 |
37,303,752 |
RGD:2317756 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
Disease_progression |
ISS |
3 |
37,247,575 |
37,303,752 |
RGD:2317758 |
RGD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
Disease_progression |
ISS |
5 |
143,722,034 |
143,734,868 |
RGD:2317790 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
Resistance |
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:2317806 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
|
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:2317809 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
|
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:2317811 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IED |
10 |
87,321,801 |
87,399,792 |
RGD:2317639 |
RGD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
|
ISS |
7 |
75,097,143 |
75,378,553 |
RGD:2317652 |
RGD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
|
ISS |
7 |
75,097,143 |
75,378,553 |
RGD:2317649 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
11 |
53,425,962 |
53,432,167 |
RGD:2317264 |
RGD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
|
ISS |
7 |
132,695,796 |
132,722,988 |
RGD:2317264 |
RGD |
| G |
Ins2 |
insulin II |
|
|
ISS |
7 |
149,864,561 |
149,865,613 |
RGD:2317248 |
RGD |
| G |
Krt7 |
keratin 7 |
|
Disease_progression |
ISS |
15 |
101,242,834 |
101,258,237 |
RGD:2317307 |
RGD |
| G |
L1cam |
L1 cell adhesion molecule |
|
Severity |
ISS |
X |
71,099,119 |
71,126,173 |
RGD:6483447 |
RGD |
| G |
Mcm7 |
minichromosome maintenance deficient 7 (S. cerevisiae) |
|
|
ISS |
5 |
138,605,817 |
138,613,090 |
RGD:2317697 |
RGD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
Severity |
ISS |
10 |
117,125,961 |
117,147,772 |
RGD:2317416 |
RGD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
Onset |
ISS |
10 |
117,125,961 |
117,147,772 |
RGD:2317414 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
|
ISS |
19 |
6,334,979 |
6,340,894 |
RGD:2317294 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317530 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317664 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
Susceptibility |
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317648 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Severity |
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2325746 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2325844 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2325830 |
RGD |
| G |
Msln |
mesothelin |
|
Disease_progression |
ISS |
17 |
25,885,558 |
25,891,272 |
RGD:2326055 |
RGD |
| G |
Msln |
mesothelin |
|
|
ISS |
17 |
25,885,558 |
25,891,272 |
RGD:2326065 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
Disease_progression |
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324633 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2317983 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
Disease_progression |
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324616 |
RGD |
| G |
Muc4 |
mucin 4 |
|
|
ISS |
16 |
32,735,972 |
32,782,477 |
RGD:2324946 |
RGD |
| G |
Muc4 |
mucin 4 |
|
Disease_progression |
ISS |
16 |
32,735,972 |
32,782,477 |
RGD:2324942 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
|
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324986 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
Disease_progression |
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324907 |
RGD |
| G |
Muc5b |
mucin 5, subtype B, tracheobronchial |
|
|
ISS |
7 |
149,024,977 |
149,058,990 |
RGD:2324986 |
RGD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
|
ISS |
11 |
93,820,239 |
93,829,835 |
RGD:5132867 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IPM |
11 |
78,734,361 |
78,773,626 |
RGD:2325254 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
IPM |
2 |
26,313,422 |
26,359,342 |
RGD:2325323 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
IPM |
2 |
26,313,422 |
26,359,342 |
RGD:2325324 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
Disease_progression |
ISS |
7 |
85,337,000 |
85,722,724 |
RGD:2325660 |
RGD |
| G |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
|
ISS |
7 |
85,337,000 |
85,722,724 |
RGD:2325663 |
RGD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
|
ISS |
8 |
63,993,818 |
64,381,487 |
RGD:2325781 |
RGD |
| G |
Pms1 |
postmeiotic segregation increased 1 (S. cerevisiae) |
|
|
ISS |
1 |
53,246,031 |
53,353,840 |
RGD:2324870 |
RGD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
Disease_progression |
ISS |
6 |
115,311,239 |
115,440,419 |
RGD:2317461 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
1 |
151,947,254 |
151,955,147 |
RGD:2317185 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
Severity |
ISS |
2 |
27,532,721 |
27,618,839 |
RGD:2317461 |
RGD |
| G |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
|
|
ISS |
12 |
105,185,141 |
105,195,107 |
RGD:2317811 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
IEP |
3 |
28,596,825 |
28,627,283 |
RGD:2324975 |
RGD |
| G |
Smo |
smoothened homolog (Drosophila) |
|
|
ISS |
6 |
29,685,497 |
29,711,366 |
RGD:2324981 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
7 |
26,472,021 |
26,490,015 |
RGD:2325019 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
Disease_progression |
ISS |
9 |
115,996,813 |
116,084,481 |
RGD:2317500 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
IPM |
9 |
115,996,813 |
116,084,481 |
RGD:2317498 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
2 |
117,937,658 |
117,952,869 |
RGD:2325022 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
Disease_progression |
ISS |
2 |
117,937,658 |
117,952,869 |
RGD:2325025 |
RGD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
|
ISS |
17 |
31,316,210 |
31,335,919 |
RGD:2325152 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
Disease_progression |
ISS |
15 |
89,202,362 |
89,207,467 |
RGD:2325155 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
|
ISS |
6 |
113,574,015 |
113,581,627 |
RGD:2325022 |
RGD |
Carcinoma, Renal Cell
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
|
ISS |
5 |
8,660,092 |
8,748,570 |
RGD:2315559 |
RGD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
Disease_progression |
ISS |
5 |
8,660,092 |
8,748,570 |
RGD:2315557 |
RGD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
Susceptibility |
ISS |
6 |
58,546,666 |
58,642,445 |
RGD:2315569 |
RGD |
| G |
Afp |
alpha fetoprotein |
|
|
ISS |
5 |
90,919,740 |
90,937,933 |
RGD:2292042 |
RGD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
Severity |
ISS |
13 |
30,428,225 |
30,474,736 |
RGD:6903280 |
RGD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
Disease_progression |
ISS |
X |
21,061,752 |
21,065,957 |
RGD:6903280 |
RGD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
|
ISS |
12 |
113,892,032 |
113,912,487 |
RGD:1643331 |
RGD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
|
ISS |
11 |
70,054,957 |
70,068,843 |
RGD:2315610 |
RGD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
|
ISS |
15 |
10,911,511 |
10,926,379 |
RGD:2315633 |
RGD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
|
ISS |
14 |
51,710,752 |
51,721,684 |
RGD:2325699 |
RGD |
| G |
Angpt1 |
angiopoietin 1 |
|
Severity |
ISS |
15 |
42,256,269 |
42,508,341 |
RGD:1643335 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
Severity |
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:7242059 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
Onset |
IPM |
18 |
34,380,638 |
34,481,844 |
RGD:7242056 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
Disease_progression |
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:7242060 |
RGD |
| G |
Aurka |
aurora kinase A |
|
|
ISS |
2 |
172,181,696 |
172,196,006 |
RGD:1643346 |
RGD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
|
ISS |
19 |
7,016,345 |
7,026,383 |
RGD:2292677 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
Severity |
ISS |
17 |
27,156,757 |
27,165,571 |
RGD:2315703 |
RGD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
Disease_progression |
ISS |
1 |
108,434,756 |
108,610,867 |
RGD:2293019 |
RGD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
|
ISS |
1 |
108,434,756 |
108,610,867 |
RGD:2298896 |
RGD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
|
ISS |
2 |
152,606,404 |
152,657,418 |
RGD:1643483 |
RGD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
Disease_progression |
ISS |
9 |
7,818,226 |
7,835,255 |
RGD:1643526 |
RGD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
|
ISS |
9 |
7,848,699 |
7,873,170 |
RGD:1643526 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
Disease_progression |
ISS |
11 |
117,710,551 |
117,717,057 |
RGD:2293102 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
ISS |
11 |
117,710,551 |
117,717,057 |
RGD:2293108 |
RGD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
Severity |
ISS |
14 |
47,003,195 |
47,010,274 |
RGD:1643589 |
RGD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
|
ISS |
13 |
38,437,585 |
38,591,597 |
RGD:7242419 |
RGD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
Disease_progression |
ISS |
2 |
172,695,187 |
172,765,794 |
RGD:1643589 |
RGD |
| G |
Bsg |
basigin |
|
Disease_progression |
ISS |
10 |
79,167,103 |
79,174,724 |
RGD:2289052 |
RGD |
| G |
Btg2 |
B cell translocation gene 2, anti-proliferative |
|
|
ISS |
1 |
135,971,442 |
135,975,732 |
RGD:2289069 |
RGD |
| G |
C4a |
complement component 4A (Rodgers blood group) |
|
Disease_progression |
ISS |
17 |
34,946,037 |
34,960,399 |
RGD:5688259 |
RGD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
Disease_progression |
ISS |
17 |
34,865,325 |
34,880,842 |
RGD:5688259 |
RGD |
| G |
Car9 |
carbonic anhydrase 9 |
|
|
ISS |
4 |
43,519,898 |
43,526,597 |
RGD:2293201 |
RGD |
| G |
Car9 |
carbonic anhydrase 9 |
|
Disease_progression |
ISS |
4 |
43,519,898 |
43,526,597 |
RGD:2293191 |
RGD |
| G |
Car9 |
carbonic anhydrase 9 |
|
|
ISS |
4 |
43,519,898 |
43,526,597 |
RGD:2293199 |
RGD |
| G |
Car9 |
carbonic anhydrase 9 |
|
|
ISS |
4 |
43,519,898 |
43,526,597 |
RGD:2293198 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
ISS |
8 |
47,702,803 |
47,724,071 |
RGD:2293308 |
RGD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
Disease_progression |
ISS |
6 |
17,256,370 |
17,291,324 |
RGD:2289107 |
RGD |
| G |
Ccnb1 |
cyclin B1 |
|
Disease_progression |
ISS |
13 |
101,548,694 |
101,556,441 |
RGD:2315941 |
RGD |
| G |
Ccnd1 |
cyclin D1 |
|
|
ISS |
7 |
152,115,836 |
152,125,830 |
RGD:2289130 |
RGD |
| G |
Ccnd1 |
cyclin D1 |
|
|
ISS |
7 |
152,115,836 |
152,125,830 |
RGD:2289127 |
RGD |
| G |
Ccnd3 |
cyclin D3 |
|
Disease_progression |
ISS |
17 |
47,642,000 |
47,736,638 |
RGD:2316007 |
RGD |
| G |
Ccne1 |
cyclin E1 |
|
|
ISS |
7 |
38,883,003 |
38,892,509 |
RGD:2289228 |
RGD |
| G |
Cd44 |
CD44 antigen |
|
Disease_progression |
ISS |
2 |
102,651,298 |
102,741,822 |
RGD:2289360 |
RGD |
| G |
Cd44 |
CD44 antigen |
|
Severity |
ISS |
2 |
102,651,298 |
102,741,822 |
RGD:2289351 |
RGD |
| G |
Cd46 |
CD46 antigen, complement regulatory protein |
|
|
ISS |
1 |
196,868,094 |
196,918,442 |
RGD:2293550 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
Disease_progression |
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:2289489 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
Onset |
ISS |
8 |
109,127,268 |
109,194,146 |
RGD:7242059 |
RGD |
| G |
Cdk2 |
cyclin-dependent kinase 2 |
|
|
ISS |
10 |
128,134,995 |
128,142,107 |
RGD:2293561 |
RGD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
|
ISS |
10 |
126,500,659 |
126,504,339 |
RGD:2293579 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
Disease_progression |
ISS |
6 |
134,870,419 |
134,875,543 |
RGD:2289127 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
Disease_progression |
ISS |
6 |
134,870,419 |
134,875,543 |
RGD:2293589 |
RGD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
ISS |
6 |
134,870,419 |
134,875,543 |
RGD:2293590 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
4 |
88,920,377 |
88,940,523 |
RGD:2289699 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
ISS |
4 |
88,920,377 |
88,940,523 |
RGD:2289680 |
RGD |
| G |
Comt |
catechol-O-methyltransferase |
|
Susceptibility |
ISS |
16 |
18,406,975 |
18,426,809 |
RGD:2289716 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Disease_progression |
ISS |
1 |
174,628,187 |
174,630,097 |
RGD:6904212 |
RGD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
|
ISS |
18 |
61,265,226 |
61,290,793 |
RGD:2299092 |
RGD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
|
ISS |
1 |
60,965,869 |
60,972,674 |
RGD:7204723 |
RGD |
| G |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
|
Disease_progression |
ISS |
18 |
35,278,566 |
35,414,429 |
RGD:2289799 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
Disease_progression |
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:2289794 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
Disease_progression |
ISS |
9 |
120,842,518 |
120,869,625 |
RGD:2289835 |
RGD |
| G |
Dirc2 |
disrupted in renal carcinoma 2 (human) |
|
Susceptibility |
ISS |
16 |
35,694,989 |
35,769,442 |
RGD:1601072 |
RGD |
| G |
Dirc2 |
disrupted in renal carcinoma 2 (human) |
|
|
ISS |
16 |
35,694,989 |
35,769,442 |
RGD:7240710 |
OMIM |
| G |
Ebag9 |
estrogen receptor-binding fragment-associated gene 9 |
|
Disease_progression |
IPM |
15 |
44,451,187 |
44,472,573 |
RGD:2289852 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
11 |
16,652,206 |
16,813,910 |
RGD:2293730 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289930 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289987 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISS |
1 |
68,086,540 |
69,154,633 |
RGD:2289987 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
|
IAGP |
19 |
34,365,149 |
34,402,260 |
RGD:2290132 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
|
ISS |
19 |
34,365,149 |
34,402,260 |
RGD:2290099 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
|
ISS |
19 |
34,365,149 |
34,402,260 |
RGD:2290131 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
|
ISS |
19 |
34,365,149 |
34,402,260 |
RGD:2290133 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
IED |
1 |
163,710,820 |
163,718,626 |
RGD:2290051 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
IAGP |
1 |
163,710,820 |
163,718,626 |
RGD:2290132 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
Disease_progression |
ISS |
3 |
37,247,575 |
37,303,752 |
RGD:2290303 |
RGD |
| G |
Fh1 |
fumarate hydratase 1 |
|
|
ISS |
1 |
177,531,509 |
177,555,766 |
RGD:6907135 |
RGD |
| G |
Fhit |
fragile histidine triad gene |
|
|
ISS |
14 |
10,382,608 |
11,994,546 |
RGD:2289903 |
RGD |
| G |
Fhit |
fragile histidine triad gene |
|
|
ISS |
14 |
10,382,608 |
11,994,546 |
RGD:2289870 |
RGD |
| G |
Flcn |
folliculin |
|
|
ISS |
11 |
59,605,252 |
59,623,275 |
RGD:7240710 |
OMIM |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
|
ISS |
5 |
148,373,772 |
148,537,564 |
RGD:2289960 |
RGD |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
|
ISS |
5 |
148,373,772 |
148,537,564 |
RGD:2301250 |
RGD |
| G |
Fn1 |
fibronectin 1 |
|
Severity |
ISS |
1 |
71,632,097 |
71,699,745 |
RGD:7205637 |
RGD |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
ISS |
2 |
157,155,232 |
157,172,391 |
RGD:2301426 |
RGD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
Susceptibility |
ISS |
3 |
107,815,168 |
107,820,891 |
RGD:2293845 |
RGD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
Susceptibility |
ISS |
10 |
75,246,558 |
75,261,329 |
RGD:2293845 |
RGD |
| G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
Susceptibility |
ISS |
17 |
34,442,812 |
34,453,619 |
RGD:2314704 |
RGD |
| G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
Susceptibility |
ISS |
17 |
34,442,812 |
34,453,619 |
RGD:2314701 |
RGD |
| G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
Disease_progression |
ISS |
17 |
34,442,812 |
34,453,619 |
RGD:2314695 |
RGD |
| G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
|
Disease_progression |
ISS |
12 |
75,008,854 |
75,048,517 |
RGD:2306222 |
RGD |
| G |
Hnf1a |
HNF1 homeobox A |
|
|
ISS |
5 |
115,398,989 |
115,421,071 |
RGD:7240710 |
OMIM |
| G |
Hnf1b |
HNF1 homeobox B |
|
|
ISS |
11 |
83,664,371 |
83,719,317 |
RGD:7240710 |
OMIM |
| G |
Hoxb13 |
homeobox B13 |
|
Disease_progression |
ISS |
11 |
96,055,675 |
96,057,913 |
RGD:2314729 |
RGD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
|
ISS |
11 |
7,106,089 |
7,113,926 |
RGD:2290003 |
RGD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
|
ISS |
5 |
77,778,265 |
77,837,070 |
RGD:1626565 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
2 |
24,192,380 |
24,207,011 |
RGD:6907413 |
RGD |
| G |
Il2 |
interleukin 2 |
|
|
ISS |
3 |
37,019,635 |
37,024,876 |
RGD:5147871 |
RGD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
Susceptibility |
ISS |
7 |
132,695,796 |
132,722,988 |
RGD:7207066 |
RGD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
Disease_progression |
ISS |
7 |
132,695,796 |
132,722,988 |
RGD:7207070 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISS |
8 |
3,150,922 |
3,279,617 |
RGD:2290462 |
RGD |
| G |
Jun |
Jun oncogene |
|
|
ISS |
4 |
94,715,727 |
94,718,913 |
RGD:1549443 |
RGD |
| G |
Jup |
junction plakoglobin |
|
|
ISS |
11 |
100,231,933 |
100,259,053 |
RGD:2291866 |
RGD |
| G |
Jup |
junction plakoglobin |
|
|
ISS |
11 |
100,231,933 |
100,259,053 |
RGD:2291890 |
RGD |
| G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
|
ISS |
19 |
25,311,692 |
25,508,986 |
RGD:2315654 |
RGD |
| G |
Kdm5c |
lysine (K)-specific demethylase 5C |
|
|
ISS |
X |
148,667,773 |
148,708,897 |
RGD:6907133 |
RGD |
| G |
Kdm5c |
lysine (K)-specific demethylase 5C |
|
|
ISS |
X |
148,667,773 |
148,708,897 |
RGD:6907137 |
RGD |
| G |
Kdm6a |
lysine (K)-specific demethylase 6A |
|
|
ISS |
X |
17,739,793 |
17,856,484 |
RGD:6907133 |
RGD |
| G |
Kdm6a |
lysine (K)-specific demethylase 6A |
|
|
ISS |
X |
17,739,793 |
17,856,484 |
RGD:6907137 |
RGD |
| G |
Kdr |
kinase insert domain protein receptor |
|
|
IPM |
5 |
76,329,290 |
76,374,453 |
RGD:2301756 |
RGD |
| G |
Kit |
kit oncogene |
|
|
ISS |
5 |
75,971,012 |
76,052,747 |
RGD:2292414 |
RGD |
| G |
Kit |
kit oncogene |
|
|
ISS |
5 |
75,971,012 |
76,052,747 |
RGD:2292421 |
RGD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
|
ISS |
7 |
51,079,914 |
51,087,397 |
RGD:2314864 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
6 |
145,165,219 |
145,198,751 |
RGD:2314914 |
RGD |
| G |
Lep |
leptin |
|
Resistance |
ISS |
6 |
29,010,221 |
29,023,876 |
RGD:6907119 |
RGD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
|
ISS |
17 |
17,664,687 |
17,761,453 |
RGD:2314919 |
RGD |
| G |
Ltf |
lactotransferrin |
|
|
ISS |
9 |
110,921,796 |
110,945,270 |
RGD:7243106 |
RGD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
Susceptibility |
ISS |
9 |
106,789,746 |
106,794,269 |
RGD:1599220 |
RGD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
|
ISS |
9 |
64,033,600 |
64,101,412 |
RGD:2292629 |
RGD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
|
ISS |
9 |
64,033,600 |
64,101,412 |
RGD:2292630 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:1600122 |
RGD |
| G |
Mgp |
matrix Gla protein |
|
Disease_progression |
ISS |
6 |
136,820,956 |
136,824,326 |
RGD:2293578 |
RGD |
| G |
Mlh1 |
mutL homolog 1 (E. coli) |
|
|
ISS |
9 |
111,130,732 |
111,174,112 |
RGD:2293509 |
RGD |
| G |
Mmp1a |
matrix metallopeptidase 1a (interstitial collagenase) |
|
Susceptibility |
ISS |
9 |
7,464,141 |
7,476,869 |
RGD:7207023 |
RGD |
| G |
Mmp1a |
matrix metallopeptidase 1a (interstitial collagenase) |
|
No_Association |
ISS |
9 |
7,464,141 |
7,476,869 |
RGD:7207082 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Disease_progression |
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2290359 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2290358 |
RGD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
|
ISS |
9 |
7,445,822 |
7,455,975 |
RGD:7241233 |
RGD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
|
ISS |
9 |
7,445,822 |
7,455,975 |
RGD:7207067 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2290358 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISS |
17 |
88,071,897 |
88,123,053 |
RGD:2293509 |
RGD |
| G |
Mthfr |
5,10-methylenetetrahydrofolate reductase |
|
Susceptibility |
ISS |
4 |
147,413,186 |
147,433,671 |
RGD:6893654 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7207841 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7207793 |
RGD |
| G |
Nf2 |
neurofibromatosis 2 |
|
|
IAGP |
11 |
4,665,851 |
4,749,530 |
RGD:2315000 |
RGD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
Disease_progression |
ISS |
11 |
93,820,239 |
93,829,835 |
RGD:2299059 |
RGD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
|
ISS |
9 |
48,399,995 |
48,413,182 |
RGD:2299120 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
Treatment |
ISS |
18 |
39,570,199 |
39,646,899 |
RGD:7174733 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
Severity |
ISS |
18 |
39,570,199 |
39,646,899 |
RGD:7174727 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
|
ISS |
6 |
113,276,970 |
113,284,182 |
RGD:2317140 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
|
ISS |
6 |
113,276,970 |
113,284,182 |
RGD:1600295 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
|
ISS |
6 |
113,276,970 |
113,284,182 |
RGD:7240710 |
OMIM |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
|
ISS |
7 |
104,991,449 |
105,060,891 |
RGD:2299159 |
RGD |
| G |
Pbrm1 |
polybromo 1 |
|
|
ISS |
14 |
31,832,324 |
31,934,778 |
RGD:6907133 |
RGD |
| G |
Pbrm1 |
polybromo 1 |
|
|
ISS |
14 |
31,832,324 |
31,934,778 |
RGD:6907137 |
RGD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
Severity |
ISS |
2 |
132,075,022 |
132,078,916 |
RGD:2315008 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
Disease_progression |
ISS |
5 |
75,548,316 |
75,594,229 |
RGD:2292157 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
61,204,804 |
61,244,721 |
RGD:2292198 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
61,204,804 |
61,244,721 |
RGD:2290496 |
RGD |
| G |
Pdpn |
podoplanin |
|
Disease_progression |
ISS |
4 |
142,857,325 |
142,889,410 |
RGD:2292239 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
Severity |
ISS |
14 |
21,655,884 |
21,662,610 |
RGD:7241133 |
RGD |
| G |
Pld2 |
phospholipase D2 |
|
|
ISS |
11 |
70,353,666 |
70,371,612 |
RGD:2299898 |
RGD |
| G |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
|
|
ISS |
2 |
173,049,966 |
173,102,034 |
RGD:2315108 |
RGD |
| G |
Prcc |
papillary renal cell carcinoma (translocation-associated) |
|
|
ISS |
3 |
87,662,825 |
87,689,484 |
RGD:7240710 |
OMIM |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
19 |
32,832,067 |
32,900,650 |
RGD:2292500 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
19 |
32,832,067 |
32,900,650 |
RGD:1643331 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
Disease_progression |
ISS |
19 |
32,832,067 |
32,900,650 |
RGD:2292513 |
RGD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
|
ISS |
2 |
36,085,946 |
36,107,789 |
RGD:2300212 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2300212 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Disease_progression |
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2300204 |
RGD |
| G |
Rage |
renal tumor antigen |
|
|
ISS |
|
|
|
RGD:7243170 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISS |
9 |
107,456,987 |
107,464,591 |
RGD:2291977 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISS |
9 |
107,456,987 |
107,464,591 |
RGD:2299866 |
RGD |
| G |
Rb1 |
retinoblastoma 1 |
|
Disease_progression |
ISS |
14 |
73,595,309 |
73,725,598 |
RGD:2299893 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
ISS |
19 |
5,637,490 |
5,648,130 |
RGD:2298771 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
ISS |
19 |
5,637,490 |
5,648,130 |
RGD:2298755 |
RGD |
| G |
Rnf139 |
ring finger protein 139 |
|
|
ISS |
15 |
58,720,784 |
58,733,945 |
RGD:1599629 |
RGD |
| G |
Rnf139 |
ring finger protein 139 |
|
|
ISS |
15 |
58,720,784 |
58,733,945 |
RGD:2289870 |
RGD |
| G |
Rnf139 |
ring finger protein 139 |
|
|
ISS |
15 |
58,720,784 |
58,733,945 |
RGD:7240710 |
OMIM |
| G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
|
ISS |
4 |
140,517,186 |
140,535,108 |
RGD:6907134 |
RGD |
| G |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
|
ISS |
9 |
50,404,445 |
50,411,954 |
RGD:6907134 |
RGD |
| G |
Setd2 |
SET domain containing 2 |
|
|
ISS |
9 |
110,435,101 |
110,521,137 |
RGD:6907133 |
RGD |
| G |
Setd2 |
SET domain containing 2 |
|
|
ISS |
9 |
110,435,101 |
110,521,137 |
RGD:6907137 |
RGD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
|
ISS |
8 |
24,521,974 |
24,560,104 |
RGD:4107084 |
RGD |
| G |
Skp2 |
S-phase kinase-associated protein 2 (p45) |
|
Disease_progression |
ISS |
15 |
9,041,742 |
9,070,207 |
RGD:2315038 |
RGD |
| G |
Smad2 |
SMAD family member 2 |
|
Severity |
ISS |
18 |
76,401,579 |
76,465,385 |
RGD:2299973 |
RGD |
| G |
Smad4 |
SMAD family member 4 |
|
Severity |
ISS |
18 |
73,798,667 |
73,863,395 |
RGD:2299973 |
RGD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
|
ISS |
11 |
55,208,003 |
55,233,582 |
RGD:2300025 |
RGD |
| G |
Spink3 |
serine peptidase inhibitor, Kazal type 3 |
|
|
ISS |
18 |
43,887,723 |
43,896,891 |
RGD:2300388 |
RGD |
| G |
Spink3 |
serine peptidase inhibitor, Kazal type 3 |
|
Disease_progression |
ISS |
18 |
43,887,723 |
43,896,891 |
RGD:2300387 |
RGD |
| G |
St14 |
suppression of tumorigenicity 14 (colon carcinoma) |
|
|
ISS |
9 |
30,896,175 |
30,939,384 |
RGD:2315090 |
RGD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
|
ISS |
11 |
100,748,124 |
100,800,825 |
RGD:2291913 |
RGD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
Disease_progression |
ISS |
11 |
100,748,124 |
100,800,825 |
RGD:2291917 |
RGD |
| G |
Terc |
telomerase RNA component |
|
|
ISS |
3 |
96,218,360 |
96,218,756 |
RGD:2291972 |
RGD |
| G |
Tert |
telomerase reverse transcriptase |
|
|
ISS |
13 |
73,764,449 |
73,786,489 |
RGD:2291980 |
RGD |
| G |
Tfe3 |
transcription factor E3 |
|
|
ISS |
X |
7,339,787 |
7,352,328 |
RGD:1599384 |
RGD |
| G |
Tfrc |
transferrin receptor |
|
|
ISS |
16 |
32,608,982 |
32,632,880 |
RGD:2292025 |
RGD |
| G |
Tfrc |
transferrin receptor |
|
|
ISS |
16 |
32,608,982 |
32,632,880 |
RGD:2292024 |
RGD |
| G |
Thra |
thyroid hormone receptor alpha |
|
|
ISS |
11 |
98,603,187 |
98,626,425 |
RGD:2315097 |
RGD |
| G |
Thrb |
thyroid hormone receptor beta |
|
|
ISS |
14 |
18,493,474 |
18,870,602 |
RGD:2315097 |
RGD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
Disease_progression |
ISS |
X |
20,447,292 |
20,451,863 |
RGD:2290350 |
RGD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
|
ISS |
11 |
118,162,375 |
118,216,725 |
RGD:2290358 |
RGD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
Disease_progression |
ISS |
11 |
118,162,375 |
118,216,725 |
RGD:2290359 |
RGD |
| G |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
|
|
ISS |
10 |
85,763,157 |
85,812,250 |
RGD:2290421 |
RGD |
| G |
Timp4 |
tissue inhibitor of metalloproteinase 4 |
|
|
ISS |
6 |
115,195,634 |
115,201,867 |
RGD:2290421 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
17 |
35,336,335 |
35,338,941 |
RGD:2315119 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
17 |
35,336,335 |
35,338,941 |
RGD:2315113 |
RGD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
|
ISS |
14 |
70,167,279 |
70,184,218 |
RGD:2290496 |
RGD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
|
ISS |
14 |
70,167,279 |
70,184,218 |
RGD:2290491 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
ISS |
6 |
125,299,741 |
125,312,501 |
RGD:5131437 |
RGD |
| G |
Trp53 |
transformation related protein 53 |
|
Disease_progression |
ISS |
11 |
69,393,861 |
69,405,375 |
RGD:2290544 |
RGD |
| G |
Trp73 |
transformation related protein 73 |
|
|
ISS |
4 |
153,430,358 |
153,514,317 |
RGD:2291837 |
RGD |
| G |
Txnip |
thioredoxin interacting protein |
|
|
ISS |
3 |
96,361,880 |
96,365,780 |
RGD:1642756 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
Severity |
ISS |
15 |
89,202,362 |
89,207,467 |
RGD:2293723 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
|
ISS |
15 |
89,202,362 |
89,207,467 |
RGD:2293717 |
RGD |
| G |
Vdr |
vitamin D receptor |
|
|
IEA |
15 |
97,684,858 |
97,738,727 |
RGD:1331525 |
RGD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
Disease_progression |
ISS |
17 |
46,153,942 |
46,169,326 |
RGD:2315455 |
RGD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
|
ISS |
8 |
55,162,886 |
55,271,808 |
RGD:2315476 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
|
ISS |
6 |
113,574,015 |
113,581,627 |
RGD:6907133 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
|
ISS |
6 |
113,574,015 |
113,581,627 |
RGD:1580369 |
RGD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor |
|
|
ISS |
6 |
113,574,015 |
113,581,627 |
RGD:7240710 |
OMIM |
| G |
Vwf |
Von Willebrand factor homolog |
|
Disease_progression |
ISS |
6 |
125,502,981 |
125,636,695 |
RGD:7207032 |
RGD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
|
ISS |
10 |
120,471,060 |
120,537,698 |
RGD:2291869 |
RGD |
| G |
Wnt11 |
wingless-related MMTV integration site 11 |
|
|
ISS |
7 |
105,987,355 |
106,003,257 |
RGD:2299947 |
RGD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
Disease_progression |
ISS |
X |
39,421,013 |
39,462,841 |
RGD:2315854 |
RGD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
Susceptibility |
ISS |
7 |
25,332,169 |
25,358,457 |
RGD:2302577 |
RGD |
Carcinoma, Signet Ring Cell
|
| G |
Tff1 |
trefoil factor 1 |
|
|
ISS |
17 |
31,298,341 |
31,301,998 |
RGD:2291996 |
RGD |
Cholangiocarcinoma
|
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
Susceptibility |
ISS |
19 |
43,856,798 |
43,912,708 |
RGD:2317508 |
RGD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
|
ISS |
18 |
62,337,470 |
62,339,613 |
RGD:2325640 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
5 |
90,889,915 |
90,905,629 |
RGD:2325682 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
5 |
90,889,915 |
90,905,629 |
RGD:2325679 |
RGD |
| G |
Alb |
albumin |
|
Disease_progression |
ISS |
5 |
90,889,915 |
90,905,629 |
RGD:2325680 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
6 |
116,360,089 |
116,411,196 |
RGD:2317521 |
RGD |
| G |
Anxa2 |
annexin A2 |
|
Disease_progression |
ISS |
9 |
69,301,490 |
69,339,592 |
RGD:2325728 |
RGD |
| G |
Anxa8 |
annexin A8 |
|
|
ISS |
14 |
34,899,176 |
34,913,757 |
RGD:2325733 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
|
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:2317198 |
RGD |
| G |
Apc |
adenomatosis polyposis coli |
|
|
ISS |
18 |
34,380,638 |
34,481,844 |
RGD:2317205 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISS |
9 |
46,036,713 |
46,038,549 |
RGD:2325756 |
RGD |
| G |
Cycs |
cytochrome c, somatic |
|
|
ISS |
6 |
50,512,562 |
50,516,473 |
RGD:2317615 |
RGD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
|
ISS |
1 |
163,710,820 |
163,718,626 |
RGD:2317746 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
3 |
37,247,575 |
37,303,752 |
RGD:2317765 |
RGD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
Disease_progression |
ISS |
5 |
143,722,034 |
143,734,868 |
RGD:2317780 |
RGD |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
Disease_progression |
ISS |
2 |
174,109,821 |
174,172,245 |
RGD:1601377 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
|
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:2317198 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
5 |
16,059,368 |
16,125,257 |
RGD:2317925 |
RGD |
| G |
Hgf |
hepatocyte growth factor |
|
|
ISS |
5 |
16,059,368 |
16,125,257 |
RGD:2317909 |
RGD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
|
ISS |
7 |
132,695,796 |
132,722,988 |
RGD:2317263 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
5 |
30,339,701 |
30,346,508 |
RGD:2317167 |
RGD |
| G |
Krt7 |
keratin 7 |
|
|
ISS |
15 |
101,242,834 |
101,258,237 |
RGD:2317308 |
RGD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
Disease_progression |
ISS |
10 |
117,125,961 |
117,147,772 |
RGD:2317417 |
RGD |
| G |
Met |
met proto-oncogene |
|
Disease_progression |
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317578 |
RGD |
| G |
Met |
met proto-oncogene |
|
Disease_progression |
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317601 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317632 |
RGD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
Disease_progression |
ISS |
7 |
142,881,471 |
142,908,062 |
RGD:2317705 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2324667 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Disease_progression |
ISS |
8 |
95,351,227 |
95,377,319 |
RGD:2325769 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2324667 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2325856 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
2 |
164,773,751 |
164,781,346 |
RGD:2324667 |
RGD |
| G |
Mthfr |
5,10-methylenetetrahydrofolate reductase |
|
Susceptibility |
ISS |
4 |
147,413,186 |
147,433,671 |
RGD:2317119 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324622 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
Disease_progression |
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2317986 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324664 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324667 |
RGD |
| G |
Muc1 |
mucin 1, transmembrane |
|
|
ISS |
3 |
89,032,974 |
89,037,291 |
RGD:2324638 |
RGD |
| G |
Muc16 |
mucin 16 |
|
|
ISS |
9 |
18,299,899 |
18,317,332 |
RGD:2325142 |
RGD |
| G |
Muc2 |
mucin 2 |
|
|
ISS |
7 |
148,876,261 |
148,890,250 |
RGD:2324948 |
RGD |
| G |
Muc4 |
mucin 4 |
|
Disease_progression |
ISS |
16 |
32,735,972 |
32,782,477 |
RGD:2324944 |
RGD |
| G |
Muc4 |
mucin 4 |
|
|
ISS |
16 |
32,735,972 |
32,782,477 |
RGD:2303602 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
|
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324948 |
RGD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
Disease_progression |
ISS |
7 |
148,974,916 |
149,005,040 |
RGD:2324990 |
RGD |
| G |
Muc5b |
mucin 5, subtype B, tracheobronchial |
|
|
ISS |
7 |
149,024,977 |
149,058,990 |
RGD:2324948 |
RGD |
| G |
Muc6 |
mucin 6, gastric |
|
|
ISS |
7 |
148,819,948 |
148,841,207 |
RGD:2325167 |
RGD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
|
ISS |
8 |
70,018,774 |
70,026,479 |
RGD:2317172 |
RGD |
| G |
Ncam1 |
neural cell adhesion molecule 1 |
|
|
ISS |
9 |
49,310,243 |
49,607,174 |
RGD:2326079 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
11 |
78,734,361 |
78,773,626 |
RGD:2325280 |
RGD |
| G |
Notch1 |
notch 1 |
|
|
ISS |
2 |
26,313,422 |
26,359,342 |
RGD:2325330 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
Disease_progression |
ISS |
6 |
113,276,970 |
113,284,182 |
RGD:2317136 |
RGD |
| G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
|
Disease_progression |
ISS |
6 |
113,276,970 |
113,284,182 |
RGD:2317134 |
RGD |
| G |
Prss2 |
protease, serine, 2 |
|
|
ISS |
6 |
41,471,775 |
41,475,078 |
RGD:2324908 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
1 |
151,947,254 |
151,955,147 |
RGD:2317180 |
RGD |
| G |
Runx3 |
runt related transcription factor 3 |
|
|
ISS |
4 |
134,676,560 |
134,733,905 |
RGD:2324955 |
RGD |
| G |
Sox17 |
SRY-box containing gene 17 |
|
Severity |
ISS |
1 |
4,481,009 |
4,486,494 |
RGD:4889598 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
7 |
26,472,021 |
26,490,015 |
RGD:1299231 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Disease_progression |
ISS |
7 |
26,472,021 |
26,490,015 |
RGD:2325020 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
ISS |
9 |
115,996,813 |
116,084,481 |
RGD:1299231 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
2 |
117,937,658 |
117,952,869 |
RGD:2325024 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
Disease_progression |
ISS |
2 |
117,937,658 |
117,952,869 |
RGD:2325027 |
RGD |
| G |
Thbs1 |
thrombospondin 1 |
|
|
ISS |
2 |
117,937,658 |
117,952,869 |
RGD:2325026 |
RGD |
| G |
Tnc |
tenascin C |
|
Severity |
ISS |
4 |
63,620,819 |
63,681,760 |
RGD:4889598 |
RGD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
|
ISS |
1 |
89,967,354 |
90,116,577 |
RGD:2325161 |
RGD |
Choriocarcinoma
|
| G |
Fgf8 |
fibroblast growth factor 8 |
|
|
ISS |
19 |
45,811,288 |
45,817,374 |
RGD:2289339 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
Disease_progression |
ISS |
7 |
149,836,673 |
149,846,940 |
RGD:2290454 |
RGD |
| G |
Insr |
insulin receptor |
|
Disease_progression |
ISS |
8 |
3,150,922 |
3,279,617 |
RGD:2290454 |
RGD |
| G |
Pdgfb |
platelet derived growth factor, B polypeptide |
|
|
ISS |
15 |
79,826,304 |
79,845,238 |
RGD:2292200 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
61,204,804 |
61,244,721 |
RGD:2292200 |
RGD |
| G |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
|
|
ISS |
10 |
85,763,157 |
85,812,250 |
RGD:2290418 |
RGD |
Clear-cell metastatic renal cell carcinoma
|
| G |
F2 |
coagulation factor II |
|
|
ISS |
2 |
91,465,477 |
91,476,571 |
RGD:6893520 |
RGD |
| G |
Gstp1 |
glutathione S-transferase, pi 1 |
|
|
ISS |
19 |
4,035,411 |
4,037,912 |
RGD:6906878 |
RGD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
|
ISS |
7 |
75,097,143 |
75,378,553 |
RGD:7242921 |
RGD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
|
ISS |
9 |
7,347,374 |
7,360,461 |
RGD:2290421 |
RGD |
| G |
Mthfr |
5,10-methylenetetrahydrofolate reductase |
|
Susceptibility |
ISS |
4 |
147,413,186 |
147,433,671 |
RGD:6893474 |
RGD |
| G |
Mthfr |
5,10-methylenetetrahydrofolate reductase |
|
Severity |
ISS |
4 |
147,413,186 |
147,433,671 |
RGD:6893632 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Severity |
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7207420 |
RGD |
Cystadenocarcinoma, Mucinous
|
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
|
ISS |
17 |
89,140,889 |
89,191,316 |
RGD:2289157 |
RGD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
|
ISS |
10 |
21,601,990 |
21,719,709 |
RGD:2289157 |
RGD |
Cystadenocarcinoma, Serous
|
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
|
ISS |
17 |
89,140,889 |
89,191,316 |
RGD:2289157 |
RGD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
|
ISS |
10 |
21,601,990 |
21,719,709 |
RGD:2289157 |
RGD |
Familial medullary thyroid carcinoma
|
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
|
ISS |
3 |
87,582,166 |
87,599,084 |
RGD:7240710 |
OMIM |
| G |
Ret |
ret proto-oncogene |
|
|
ISS |
6 |
118,101,766 |
118,147,762 |
RGD:7240710 |
OMIM |
Gastrinoma
|
| G |
Igf1r |
insulin-like growth factor I receptor |
|
|
ISS |
7 |
75,097,143 |
75,378,553 |
RGD:7242847 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
|
ISS |
19 |
6,334,979 |
6,340,894 |
RGD:2317354 |
RGD |
| G |
Met |
met proto-oncogene |
|
Severity |
ISS |
6 |
17,413,957 |
17,523,980 |
RGD:2317605 |
RGD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
|
ISS |
7 |
144,086,294 |
144,319,871 |
RGD:2317340 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
3 |
28,596,825 |
28,627,283 |
RGD:2324977 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
3 |
28,596,825 |
28,627,283 |
RGD:2324976 |
RGD |
Glucagonoma
|
| G |
Btc |
betacellulin, epidermal growth factor family member |
|
|
ISS |
5 |
91,786,287 |
91,831,939 |
RGD:2326087 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
|
IPM |
19 |
6,334,979 |
6,340,894 |
RGD:2317288 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
3 |
28,596,825 |
28,627,283 |
RGD:2324977 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
ISS |
3 |
28,596,825 |
28,627,283 |
RGD:2324976 |
RGD |
| G |
Sstr4 |
somatostatin receptor 4 |
|
|
ISS |
2 |
148,221,113 |
148,222,500 |
RGD:2324994 |
RGD |
Intrahepatic cholangiocarcinoma
|
| G |
Asph |
aspartate-beta-hydroxylase |
|
|
ISS |
4 |
9,376,232 |
9,596,309 |
RGD:6902945 |
RGD |
Krukenberg Tumor
|
| G |
Cd44 |
CD44 antigen |
|
|
ISS |
2 |
102,651,298 |
102,741,822 |
RGD:2289359 |
RGD |
Paget's Disease, Mammary
|
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
11 |
98,273,798 |
98,299,030 |
RGD:2289933 |
RGD |
Papillary renal cell carcinoma, sporadic
|
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7240562 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
15 |
61,816,896 |
61,821,916 |
RGD:7240563 |
RGD |
Thyroid cancer, follicular
|
| G |
Hras1 |
Harvey rat sarcoma virus oncogene 1 |
|
|
ISS |
7 |
148,375,833 |
148,379,903 |
RGD:7240710 |
OMIM |
| G |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
|
|
ISS |
19 |
32,560,259 |
32,589,860 |
RGD:7240710 |
OMIM |
| G |
Nras |
neuroblastoma ras oncogene |
|
|
ISS |
3 |
102,862,208 |
102,871,837 |
RGD:7240710 |
OMIM |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
19 |
32,832,067 |
32,900,650 |
RGD:7240710 |
OMIM |
Term paths to the root
| Path 1 |
Diseases |
25862 |
 |
Neoplasms |
4700 |
 |
Neoplasms by Histologic Type |
1612 |
 |
Neoplasms, Glandular and Epithelial |
1048 |
 |
Carcinoma |
867 |
 |
Adenocarcinoma |
611 |
 |
Adenocarcinoid tumor |
0 |
 |
Adenocarcinoma Of Esophagus |
3 |
 |
Adenocarcinoma of lung |
2 |
 |
Adenocarcinoma, Bronchiolo-Alveolar |
4 |
 |
Adenocarcinoma, Clear Cell |
0 |
 |
Adenocarcinoma, Colorectal |
0 |
 |
Adenocarcinoma, Follicular + |
4 |
 |
Adenocarcinoma, Mucinous |
10 |
 |
Adenocarcinoma, Papillary + |
0 |
 |
Adenocarcinoma, Scirrhous + |
0 |
 |
Adenocarcinoma, Sebaceous |
0 |
 |
Adrenocortical Carcinoma + |
1 |
 |
Carcinoid Tumor + |
4 |
 |
Carcinoma, Acinar Cell |
1 |
 |
Carcinoma, Adenoid Cystic |
0 |
 |
Carcinoma, Ductal + |
102 |
 |
Carcinoma, Endometrioid |
30 |
 |
Carcinoma, Hepatocellular + |
73 |
 |
Carcinoma, Intraductal, Noninfiltrating + |
45 |
 |
Carcinoma, Islet Cell + |
12 |
 |
Carcinoma, Lobular |
10 |
 |
Carcinoma, Mucoepidermoid |
0 |
 |
Carcinoma, Neuroendocrine + |
3 |
 |
Carcinoma, Renal Cell + |
222 |
 |
Carcinoma, Signet Ring Cell + |
2 |
 |
Carcinoma, Skin Appendage |
0 |
 |
Cholangiocarcinoma + |
65 |
 |
Choriocarcinoma + |
6 |
 |
Cystadenocarcinoma + |
4 |
 |
Eccrine Porocarcinoma |
0 |
 |
Klatskin's Tumor |
0 |
 |
Paget Disease, Extramammary |
0 |
 |
Pulmonary Adenomatosis, Ovine |
0 |
 |
Urachal adenocarcinoma |
0 |
 |
| |
|